Duncan Barbara Gayle

Director at DOV PHARMACEUTICAL INC · on record since Jul 5, 2006
CEO at DOV PHARMACEUTICAL INC · on record since Aug 13, 2007
Chief Accounting Officer at INTERCEPT PHARMACEUTICALS INC · on record since Jul 7, 2016
Director at WARP TECHNOLOGY HOLDINGS INC · on record since May 7, 2026
Director at EDGETECH SERVICES INC · on record since Nov 21, 2016
Director at MEDGENICS, INC. · on record since Jul 23, 2015
Director at Adaptimmune Therapeutics PLC · on record since Jun 23, 2016
Director at Jounce Therapeutics, Inc. · on record since Jan 26, 2017
Director at Ovid Therapeutics Inc. · on record since Jun 15, 2017
Director at IMMUNOMEDICS INC · on record since Mar 7, 2019
Director at Atea Pharmaceuticals, Inc. · on record since Oct 30, 2020
Director at Fusion Pharmaceuticals Inc. · on record since Nov 3, 2020

Insider trading activity of Duncan Barbara Gayle

Transactions on record: 233; since Jul 5, 2006

Open-market buys: 1; $75K

Open-market sells: 52; $7.4M

Companies traded: 11; last filing Jun 23, 2026

Figures computed from official regulatory filings — methodology.

Companies where Duncan Barbara Gayle has traded

Atea Pharmaceuticals, Inc.17 tx · Jun 23, 2026
WARP TECHNOLOGY HOLDINGS INC9 tx · May 7, 2026
Ovid Therapeutics Inc.15 tx · Mar 2, 2026
Fusion Pharmaceuticals Inc.8 tx · Jun 4, 2024
Jounce Therapeutics, Inc.22 tx · $340.4K · May 4, 2023
Adaptimmune Therapeutics PLC6 tx · Jul 1, 2022
IMMUNOMEDICS INC14 tx · $602.4K · Oct 23, 2020
MEDGENICS, INC.13 tx · $75K · Feb 5, 2020
EDGETECH SERVICES INC2 tx · Apr 24, 2017

Track record of Duncan Barbara Gayle

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Duncan Barbara Gayle

Co-insiders of Duncan Barbara Gayle

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Atea Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	26,700	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	Exercise	29,600	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	ExerciseD	-29,600	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	37,700	0.00 USD	—	SEC
WARP TECHNOLOGY HOLDINGS INC	May 7, 2026	AwardD	6,040	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 7, 2026	Award	3,796	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Mar 2, 2026	AwardD	65,000	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	ExerciseD	-29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	AwardD	29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	AwardD	41,200	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	Exercise	29,600	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Jun 18, 2025	AwardD	45,000	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 2, 2025	AwardD	5,750	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 2, 2025	Award	4,165	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Dec 16, 2024	AwardD	90,000	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 21, 2024	AwardD	29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 21, 2024	AwardD	41,200	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 18, 2024	ExerciseD	-33,150	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 18, 2024	Exercise	33,150	0.00 USD	$0	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-30,000	—	—	SEC
WARP TECHNOLOGY HOLDINGS INC	Apr 29, 2024	AwardD	8,804	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	Apr 29, 2024	Award	6,501	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Atea Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	26,700	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	Exercise	29,600	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	ExerciseD	-29,600	0.00 USD	—	SEC
Atea Pharmaceuticals, Inc.	Jun 23, 2026	AwardD	37,700	0.00 USD	—	SEC
WARP TECHNOLOGY HOLDINGS INC	May 7, 2026	AwardD	6,040	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 7, 2026	Award	3,796	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Mar 2, 2026	AwardD	65,000	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	ExerciseD	-29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	AwardD	29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	AwardD	41,200	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 24, 2025	Exercise	29,600	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Jun 18, 2025	AwardD	45,000	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 2, 2025	AwardD	5,750	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	May 2, 2025	Award	4,165	0.00 USD	$0	SEC
Ovid Therapeutics Inc.	Dec 16, 2024	AwardD	90,000	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 21, 2024	AwardD	29,600	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 21, 2024	AwardD	41,200	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 18, 2024	ExerciseD	-33,150	0.00 USD	$0	SEC
Atea Pharmaceuticals, Inc.	Jun 18, 2024	Exercise	33,150	0.00 USD	$0	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-17,000	—	—	SEC
Fusion Pharmaceuticals Inc.	Jun 4, 2024	OtherD	-30,000	—	—	SEC
WARP TECHNOLOGY HOLDINGS INC	Apr 29, 2024	AwardD	8,804	0.00 USD	$0	SEC
WARP TECHNOLOGY HOLDINGS INC	Apr 29, 2024	Award	6,501	0.00 USD	$0	SEC